Pulmonary hypertension associated with rheumatic diseases: Baseline characteristics from the Korean registry

International Journal of Rheumatic Diseases

Volumn 15, Issue 5, 2012, Pages

  Jeon, Chan Hong ^a   Chai, Ji Young ^b   Seo, Young Il ^c   Jun, Jae Bum ^d   Koh, Eun Mi ^e   Lee, Soo Kon ^f  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Bundang Jesaeng Hospital   (South Korea)

^c Hallym University Sacred Heart Hospital   (South Korea)

^d Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

Author keywords

Connective tissue disease; Pulmonary arterial hypertension; Registries

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; AUTOANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; CARDIOPULMONARY HEMODYNAMICS; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE REGISTRY; DYSPNEA; ECHOCARDIOGRAPH; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HOME OXYGEN THERAPY; HUMAN; KOREA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIXED CONNECTIVE TISSUE DISEASE; OVERLAP SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; DATA COLLECTION; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY DIFFUSING CAPACITY; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC;

EID: 84867905967     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01815.x     Document Type: Article

References (29)

1. McLaughlin VV, Suissa S (2010) Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation 122, 106-8.
2. Rich S, Dantzker DR, Ayres SM et al. (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107, 216-23.
3. D'Alonzo GE, Barst RJ, Ayres SM et al. (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115, 343-9.
4. Humbert M (2006) Pulmonary Arterial Hypertension in France: results from a National Registry. Am J Respir Crit Care Med 173, 1023-30.
5. Fischler M, Speich R, Dorschner L et al. (2008) Pulmonary hypertension in Switzerland: treatment and clinical course. Swiss Med Wkly 138, 371-8.
6. Murata I, Takenaka K, Yoshinoya S et al. (1997) Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 111, 36-43.
7. Jing ZC, Xu XQ, Han ZY et al. (2007) Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 132, 373-9.
8. Gomberg-Maitland M, Michelakis ED (2010) A global pulmonary arterial hypertension registry: is it needed? Is it feasible? Pulmonary vascular disease: the global perspective Chest 137, 95S-101S.
9. Chung L, Liu J, Parsons L et al. (2010) Characterization of connective tissue disease associated pulmonary arterial hypertension from the REVEAL registry: identifying systemic sclerosis as a unique phenotype. Chest 138, 1383-94.
10. Magliano M, Isenberg DA, Hillson J (2002) Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 46, 1997-2009.
11. Condliffe R, Kiely DG, Peacock AJ, et al. (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179, 151-7.
12. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S (2007) An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30, 104-9.
13. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M (2007) A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 30, 1103-10.
14. Koh ET, Lee P, Gladman DD, Abu-Shakra M (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35, 989-93.
15. Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB (2006) Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 25, 866-72.
16. Benza RL, Miller DP, Gomberg-Maitland M et al. (2010) Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 122, 164-72.
17. Serdula MK, Rhoades GG (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22, 328-33.
18. Lau CS, Yin G, Mok MY (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15, 715-9.
19. Santos Estrella PV, Lin YC, Navarra SV (2007) Pulmonary arterial hypertension among Filipino patients with connective tissue diseases. Mod Rheumatol 17, 224-7.
20. McNeilage LJ, Youngchaiyud U, Whittingham S (1989) Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32, 54-60.
21. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L (2004) Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology (Oxford) 43, 1129-37.
22. Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H (2008) Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Wien Med Wochenschr 158, 19-28.
23. Schannwell CM, Steiner S, Strauer BE (2007) Diagnostics in pulmonary hypertension. J Physiol Pharmacol 58(Suppl.5), 591-602.
24. Fijalkowska A, Kurzyna M, Torbicki A, et al. (2006) Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129, 1313-21.
25. Nagaya N, Nishikimi T, Uematsu M et al. (2000) Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension. Circulation 102, 865.
26. Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2003) Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 41, 1028-35.
27. Mathai SC, Bueso M, Hummers LK et al. (2010) Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J 35, 95-104.
28. Savas N, Dagli U, Ertugrul E, Kuran S, Sahin B (2007) Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations. Dig Dis Sci 52, 3081-6.
29. Mayes MD, Lacey JV, Beebe-Dimmer J, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48, 2246-55.